Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Amyris, Inc. (AMRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.70-0.26 (-4.36%)
At close: 04:00PM EST
5.76 +0.06 (+1.05%)
After hours: 07:53PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.96
Open5.83
Bid5.76 x 36200
Ask5.75 x 3000
Day's Range5.48 - 5.89
52 Week Range3.01 - 23.42
Volume10,206,954
Avg. Volume5,055,666
Market Cap1.685B
Beta (5Y Monthly)1.44
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Amyris Consumer Brands Deliver Record Black Friday Week

    Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced strong year-over-year consumer sales performance during this year's Black Friday sales week.

  • PR Newswire

    Amyris To Present At The Evercore ISI 4th Annual HealthCONx Conference On December 1, 2021

    Amyris, Inc. (Nasdaq: AMRS) ("Amyris"), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced that management will participate in a fireside chat at the Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1st at 3:30 pm ET.

  • PR Newswire

    Amyris To Host Call Regarding Recent Financing Activity

    Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world to sustainable consumption through its Lab-to-Market™ operating platform, today announced that it will host a conference call and live webcast to discuss its recent financing activity on Monday, November 22, 2021 beginning at 6:00 a.m. Pacific Time (9:00 a.m. Eastern Time), John Melo, President and Chief Executive Officer, and Han Kieftenbeld, Chief Financial Officer, will discuss the Company's recent

Advertisement
Advertisement